Nanobiosym®, a leading nanotechnology firm,
today announced that Mr.
Ratan Tata, chairman of the multibillion-dollar global conglomerate
Tata Group, has joined the firm’s global
advisory board.
“I am honored to welcome Mr. Tata to our
Global Advisory Board,” said Nanobiosym®
Chairman and CEO, Dr.
Anita Goel, MD, PhD- a Harvard and MIT-trained physicist and
physician. “I am inspired by his example,
which provides us with a practical roadmap for bringing cutting edge
technologies into emerging global economies and extending our reach to
broad markets at the ‘bottom of the pyramid’.”
Nanobiosym® has developed Gene-RADAR®,
a portable nanotechnology platform that can rapidly and accurately
detect genetic fingerprints from any biological organism. Dr. Goel’s
vision is to give patients worldwide real-time access to their own
diagnostic information through low-cost handheld devices that could
detect disease from a single drop of blood or saliva.
“Nanotechnology has the potential to
revolutionize the way we tackle key issues facing the world today, and
Nanobiosym® is working at the forefront of
this revolution,” Mr. Tata said. “Dr.
Goel has forged a bold model for driving technological innovation and
commercialization, while maximizing global humanitarian impact. I am
delighted to join the Nanobiosym® Global
Advisory Board, and I look forward to working closely with Dr. Goel and
her team.”
Mr. Alfred Ford, Director of the Ford Motor Company Fund and also a
member of the Nanobiosym® Global Advisory
Board, said: “Behind this vision is
game-changing technology which can revolutionize healthcare globally. In
the face of growing world health crises and transnational epidemics, Dr.
Goel and Nanobiosym® are redefining the rules
in the battle to diagnose disease and save lives.”
Imagine the possibilities when a pioneer like Dr. Goel, named one of MIT
Technology Review’s top 35 science and
technology innovators in the world, aligns with a global entrepreneur
like Mr. Tata, named one of Time Magazine’s
100 most influential people in the world. Very big - and very, very
small - things can happen.
“Dr. Goel sees far over the horizon, beyond
geographic and technological boundaries, and envisions technology driven
by the needs of the greater good -- a vision that we both share,”
Mr. Tata said.
The Nanobiosym Chairman and CEO added, “We
are deeply committed to bringing our nanotech innovations into global
markets to address some of the greatest unmet humanitarian needs of our
time.”
About
Nanobiosym (www.nanobiosym.com)
Nanobiosym® and its commercial engine
Nanobiosym® Diagnostics create and
commercialize breakthrough technologies at the nexus of physics,
biomedicine, and nanotechnology. Its Gene-RADAR®
technology platform will empower people worldwide with rapid, accurate
and portable diagnostic information about their own health. Nanobiosym’s®
Global Advisory Board comprises global thought leaders who provide
guidance and strategic vision to help Nanobiosym®
realize its mission. Nanobiosym® and its
Board work closely with governmental, NGO, and commercial partners to
bring its revolutionary technology platforms into developed and emerging
world markets.
About Dr.
Anita Goel
Dr. Anita Goel, M.D., Ph.D., Chairman and CEO of Nanobiosym®,
is an internationally recognized nanotech expert and entrepreneur. Dr.
Goel’s pioneering contributions to the
interface of physics, medicine, and nanotechnology over the past 15
years have been recognized globally by several prestigious honors and
funding awards from the United States Department of Defense agencies
including Defense Advanced Research Projects Agency (DARPA), Air Force
Office of Scientific Research (AFOSR), U.S. Department of Energy (DOE)
and the U.S. Defense Threat Reduction Agency (DTRA). In 2005 Dr. Goel
was named one of the world’s “Top
35 Science and Technology Innovators under the age of 35”
by MIT’s Technology Review magazine
and in 2006 received MIT’s Global Indus
Technovator Award, an honor that recognizes the contributions of the top
10 leaders working globally at the forefront of science, technology, and
entrepreneurship. Dr. Goel holds both a Ph.D. in physics from Harvard
University and an M.D. from the Harvard-MIT Joint Division of Health
Sciences and Technology (HST).
About Mr.
Ratan N. Tata
Mr. Ratan N. Tata is Chairman of Tata Sons, the holding company for the
Tata Group, the multibillion dollar Indian conglomerate. He is also the
Chairman of two of the largest philanthropic trusts in India. Mr. Tata
is a member of the Asia-Pacific Advisory Committee to the Board of
Directors of the New York Stock Exchange and the International Advisory
Council of Singapore´s Economic Development Board, and of the advisory
boards of the Mitsubishi Corporation, JP Morgan Chase and Rolls Royce.
Mr. Tata serves as President of the Court of the Indian Institute of
Science and Chairman of the Tata Institute of Fundamental Research. He
is a member of the Board of Trustees of Cornell University and the
University of Southern California, as well as the Global Business
Council on HIV/AIDS and the Program Board of the Gates Foundation´s
India AIDS Initiative. He was recently named one of Time Magazine´s ´100
Most Influential People of 2008,´
For Nanobiosym
Media Relations:
Jen Wilson,
508-282-7156
jwilson@nanobiosym.com